VISUGROMAB
UNII NX3NW9MM9W

Substance Identification & Data

This profile provides standardized clinical and technical data for Visugromab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NX3NW9MM9W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2556646-63-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

NX3NW9MM9W

CAS Registry Number

2556646-63-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VISUGROMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C179558

National Cancer Institute reference terminology for clinical and research data.

INN ID

12044

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-193

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Visugromab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VISUGROMAB

Common Names & Synonyms

GAMMA4 HEAVY CHAIN (1-444) (VH (HOMO SAPIENS IGHV2-5*02 (92.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (10.7.10) (26-35.53-59.98-107)) (1-118)-HOMO SAPIENS IGHG4*01, G4V5 H P10 (CH1 (119-216), HINGE 1-12 S10>P (226) (217-228), CH2 (229-338), CH3 (339-443), CHS K2>DEL (444)) (119-444)), (132-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV6-15*01 (82.1%) -IGKJ2*01 (100%)/HOMO SAPIENS IGKV1-9*01 (76.8%) -IGKJ2*01 (91.7%) Q120>G (100), CDR-IMGT (6.3.9) (27-32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (224-224'':227-227'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1SV LACKING THE GLUTAMINE SYNTHETASE (GS-KO) GENE, GLYCOFORM ALFA

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS GDF15 (GROWTH DIFFERENTIATION FACTOR 15, PLAB, MIC-1, PDF, MIC1, NAG-1, PTGFB)), MONOCLONAL ANTIBODY

VISUGROMAB [INN]

VISUGROMAB [USAN]

VISUGROMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G4 (226-PROLINE,DE-445-LYSINE), ANTI-(HUMAN GROWTH DIFFERENTIATION FACTOR 15) (HUMAN-MUS MUSCULUS MONOCLONAL CTL-002 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CTL-002 .KAPPA.-CHAIN, DIMER

SYS